5 Followers on Owler
OverviewCompetitorsNews & Insights

Neurim Pharmaceuticals Competitors or Alternatives

Neurim Pharmaceuticals's top competitors include Anavex, Pfizer and AbbVie.

Unlock 20 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Neurim Pharmaceuticals's company profile

Nava Zisapel

Co-Founder & CEO

90/100
25 - 100
$0
$5M - 25M
  • $0
    $5M - 25M
  • 25 - 100
    $0
  • $5M - 25M
  • 90/100
  • 25 - 100
  • $0
  • $5M - 25M
View ProfileView
1
Neurim Pharmaceuticals's Competitor - Anavex logo

Christopher U. Missling

President & CEO

89/100
40
$60.6M
$10.9M
  • $60.6M
    $10.9M
  • 40
    $60.6M
  • $10.9M
  • 89/100
  • 40
  • $60.6M
  • $10.9M
View ProfileView
2
Neurim Pharmaceuticals's Competitor - Pfizer logo

Albert Bourla

Chairman & CEO

69/100
83,000
$1B
$63.6B
  • $1B
    $63.6B
  • 83,000
    $1B
  • $63.6B
  • 69/100
  • 83,000
  • $1B
  • $63.6B
View ProfileView
3
Neurim Pharmaceuticals's Competitor - AbbVie logo

Robert A. Michael

CEO

81/100
50,000
$6B
$56.3B
  • $6B
    $56.3B
  • 50,000
    $6B
  • $56.3B
  • 81/100
  • 50,000
  • $6B
  • $56.3B
View ProfileView
4
Neurim Pharmaceuticals's Competitor - GSK logo

Dame Emma Walmsley

CEO

67/100
70,200
$2.3B
$41B
  • $2.3B
    $41B
  • 70,200
    $2.3B
  • $41B
  • 67/100
  • 70,200
  • $2.3B
  • $41B
View ProfileView
5
Neurim Pharmaceuticals's Competitor - Biogen logo

Christopher A. Viehbacher

President & CEO

48/100
8,720
$250M
$9.7B
  • $250M
    $9.7B
  • 8,720
    $250M
  • $9.7B
  • 48/100
  • 8,720
  • $250M
  • $9.7B
View ProfileView
Neurim Pharmaceuticals' top 23 competitors are Anavex, Pfizer, AbbVie, Novartis, GSK, Biogen, Merck, Lilly, Johnson & Johnson, Roche, BrainStorm, Verge Genomics, Salarius Pharmaceuticals, Yumanity, Lysosomal Therapeutics, AstraZeneca, Bristol-Myers Squibb, Amgen, Cerecin, Gilead, Abbott, Bayer and Genentech. Together they have raised over 63.4B between their estimated 1.0M employees. Neurim Pharmaceuticals's revenue is the ranked 18th among it's top 10 competitors. The top 10 competitors average 32.3B. Neurim Pharmaceuticals has 34 employees and is ranked 22th among it's top 10 competitors. The top 10 competitors average 43,400.

Neurim Pharmaceuticals VS Anavex

Anavex is Neurim Pharmaceuticals's #1 competitor. Anavex's headquarters is in New York, New York, and was founded in 2006. Like Neurim Pharmaceuticals, Anavex also works within the Biotechnology sector. Anavex generates 88% of Neurim Pharmaceuticals's revenue.

Neurim Pharmaceuticals VS Pfizer

Pfizer is one of Neurim Pharmaceuticals's top rivals. Pfizer was founded in New York, New York} in 1849. Pfizer operates in the Pharmaceuticals industry. Compared to Neurim Pharmaceuticals, Pfizer generates $63.6B more revenue.

Neurim Pharmaceuticals VS AbbVie

AbbVie is one of Neurim Pharmaceuticals's top competitors. AbbVie is a Public company that was founded in 2013 in North Chicago, Illinois. AbbVie is in the Pharmaceuticals industry. Compared to Neurim Pharmaceuticals, AbbVie has 49,966 more employees.

Looking for similar companies to Neurim Pharmaceuticals?

Similar Companies

Biotechnology companies in Tel Aviv

See 10 companies 
Pharmaceuticals companies in Tel Aviv District

See 27 companies 
Pharmaceuticals & Biotechnology companies in Tel Aviv

See 17 companies 
Biotechnology companies in Tel Aviv District

See 33 companies 
Pharmaceuticals & Biotechnology companies in Tel Aviv District

See 53 companies 
Pharmaceuticals companies in Israel

See 161 companies 
Companies in Tel Aviv with revenue in $5.0-25M range

See 242 companies 
Biotechnology companies in Israel

See 268 companies 
Companies in Tel Aviv with employees in 25-100 range

See 366 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Neurim Pharmaceuticals and Neurim Pharmaceuticals's Competitors

April 27, 2025FinanzNachrichten
NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) announced results from the pivotal Phase 3 CREST trial of sasanlimab, an investigational anti-PD-1 monoclon...
April 26, 2025Benzinga
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Cerevel To Contact Him D...
April 27, 2025Nasdaq
(RTTNews) - Johnson & Johnson (JNJ)today announced new data from Cohort 2 of the pivotal Phase 2b SunRISe-1 study evaluating TAR-200-an intravesical ge...
April 26, 2025Pharmaceutical Processing World
Amgen announced that it plans to invest $900 million to expand its pharmaceutical manufacturing facility in Ohio. The expansion brings the total number...
April 26, 2025Yahoo
In This Article: Bristol-Myers Squibb ( NYSE:BMY ) First Quarter 2025 Results Key Financial Results Revenue: US$11.2b (down 5.6% from 1Q 2024). Net inc...
April 26, 2025Forbes
CHONGQING, CHINA - APRIL 23: In this photo illustration, the logo of Pfizer Inc. is displayed on a ... More smartphone screen, with a stock market char...
April 26, 2025centralcharts
Johnson & Johnson's TAR-200 monotherapy achieves high disease-free survival of more than 80 percent in BCG-unresponsive, high-risk papillary NMIBC PR N...

Frequently Asked Questions about Neurim Pharmaceuticals

  1. Who are Neurim Pharmaceuticals's top competitors?

    Neurim Pharmaceuticals's top 3 competitors are Anavex, Pfizer, AbbVie.

  2. Who is similar to Neurim Pharmaceuticals?

    Anavex is the most similar to Neurim Pharmaceuticals. Pfizer and AbbVie are also similar to Neurim Pharmaceuticals.

  1. Are Neurim Pharmaceuticals and Anavex competitors?

    Yes, Anavex is one of Neurim Pharmaceuticals’s top competitors.